Author： Janelsins Michelle C Tejani Mohamedtaki A Kamen Charles Peoples Anita R Mustian Karen M Morrow Gary R
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.6, 2013-04, pp. : 757-766
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Palonosetron for chemotherapy-induced nausea and vomiting
Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. :
Access to resources
Recommend
Chemotherapy-induced nausea and vomiting costly in Germany
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 450, 2004-01 ,pp. :
Chemotherapy-induced nausea and vomiting costly in Germany
Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. :
Biobehavioral Factors in Chemotherapy-Induced Nausea and Vomiting
By Roscoe Joseph A. Morrow Gary R. Hickok Jane T. Mustian Karen M. Shelke Abhay R.
Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 5, 2004-09 ,pp. :
Cambridge Scholars Publishing in association with GSE Research
Ondansetron + dexamethasone for chemotherapy-induced nausea and vomiting
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 293, 2000-01 ,pp. :